This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Melanoma in situ, other sites/unspecified
CD2_INSITU_MELANOMA_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
102 |
4. Check minimum number of eventsNone |
102 |
5. Include endpointsNone |
102 |
6. Filter based on genotype QC (FinnGen only) |
102 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Melanoma in situ, other sites/unspecified
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ, other sites/unspecified
- Melanoma in situ
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 102 | 52 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 66.86 | 63.36 | 70.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 93
- Matched controls
- 928
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
98.0
76
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
29.5
28.6
39
22
D03.8
ICD-10 Finland
Melanoma in situ of other sites
+∞
20.6
19
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
22.6
16.7
24
14
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
176.6
14.9
15
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.7
11.1
27
47
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
9.1
9.6
20
27
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
9.5
9
*
L57.0
ICD-10 Finland
Actinic keratosis
5.8
9.3
28
64
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
41.1
9.2
11
*
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
11.8
8.9
16
16
D03.5
ICD-10 Finland
Melanoma in situ of trunk
55.4
8.9
10
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
14.7
8.7
14
11
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
98.6
8.6
9
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
9.2
8.3
17
22
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.5
8.2
25
58
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
14.9
8.2
13
10
R23.8
ICD-10 Finland
Other and unspecified skin changes
4.1
7.1
30
97
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
43.3
6.9
8
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
43.3
6.9
8
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
74.8
6.5
7
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
74.8
6.5
7
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
6.3
6
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
16.4
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
10
23
4.71
4.19
1.0
1.9
—
—
—
0
0
49
301
2.21
3.73
3.7
3.1
—
—
—
0
0
80
604
2.50
3.64
5.2
3.9
14.9
14.9
pmol/l
0.04
71
538
38
212
2.26
3.64
2.6
2.0
—
—
—
0
0
58
391
2.12
3.39
5.9
6.0
1.2
1.2
mmol/l
0.73
52
351
61
424
2.09
3.23
7.0
6.6
1.2
1.2
mmol/l
1.41
47
351
58
402
2.03
3.03
3.4
3.9
0.0
0.0
estimate
0.00
15
78
57
393
2.02
3.02
4.5
3.7
—
—
—
0
0
59
414
2.01
2.95
3.4
3.9
0.0
0.0
estimate
0.00
16
72
58
407
1.99
2.88
4.2
5.2
0.0
0.0
estimate
0.00
16
77
64
486
1.85
2.30
9.5
8.6
3.9
4.3
e9/l
0.78
55
426
52
374
1.80
2.20
3.8
3.8
32.6
45.9
ng/l
0.57
35
269
7
19
3.87
2.19
1.7
1.4
—
—
—
0
0
16
79
2.22
1.98
3.6
2.0
548.1
408.7
nmol/l
0.34
16
72
43
305
1.71
1.83
3.9
4.3
—
—
—
0
0
89
776
2.15
1.83
4.9
4.3
1.3
1.3
mmol/l
0.36
82
693
34
228
1.74
1.76
4.1
4.2
0.0
0.0
estimate
0.00
15
74
13
62
2.26
1.74
5.7
2.4
5.1
5.0
kpa
0.32
13
55
41
292
1.68
1.70
2.7
3.1
2242.7
1173.9
ng/l
0.52
36
247
80
680
1.82
1.68
9.4
7.1
74.0
80.8
u/l
1.49
74
631
17
92
2.02
1.68
4.6
3.5
—
—
—
0
0
32
214
1.72
1.66
2.8
2.1
3.4
2.9
mg/l
0.64
27
188
92
820
2.24
1.65
21.9
15.3
22.3
25.3
mg/l
0.47
82
664
86
749
1.94
1.65
6.3
4.7
2.1
1.9
mu/l
0.31
77
668
95
868
2.38
1.60
23.9
17.9
88.1
81.3
umol/l
0.45
95
868
43
318
1.61
1.50
3.3
3.3
2.4
2.3
mmol/l
0.15
37
275
17
97
1.90
1.46
1.5
1.4
—
—
—
0
0
33
232
1.62
1.40
3.9
2.6
347.1
3802.2
umol/l
0.76
27
186
88
784
1.89
1.40
21.2
14.5
75.7
75.4
ml/min/173m2
0.04
79
638
90
811
1.93
1.32
5.5
4.8
4.5
4.5
mmol/l
0.04
83
742
33
237
1.58
1.27
3.9
3.1
2.0
0.6
e6/l
0.34
27
174
5
19
2.71
1.23
2.2
1.3
—
—
—
0
0
90
816
1.88
1.22
5.8
4.9
6.4
6.0
mmol/l
0.73
81
737
89
805
1.83
1.21
5.5
4.7
1.5
1.5
mmol/l
0.02
82
726
43
339
1.46
1.05
4.0
2.6
200.6
125.4
ug/l
0.82
38
305
52
428
1.44
1.01
2.0
2.6
—
—
—
0
0
90
831
1.71
0.93
5.9
5.4
2.6
2.6
mmol/l
0.00
83
754
41
330
1.41
0.87
5.8
5.0
2.6
2.0
ug/l
0.43
35
288
5
26
1.97
0.71
1.4
1.2
—
—
—
0
0
26
203
1.38
0.64
1.6
1.8
393.3
465.1
pmol/l
0.86
20
174
83
777
1.37
0.54
7.4
6.3
42.5
40.9
mmol/mol
0.62
74
722
15
110
1.43
0.52
8.1
8.9
—
—
—
0
0
8
117
0.66
0.49
1.3
1.3
—
—
—
0
0
30
253
1.26
0.44
5.4
4.5
22.1
21.5
%
0.09
16
116
5
31
1.64
0.43
1.0
1.8
—
—
—
0
0
29
244
1.26
0.43
1.5
1.6
23.7
20.8
nmol/l
0.23
21
203
5
32
1.59
0.43
1.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
9
67
1.38
0.39
2.4
1.4
—
—
—
0
0
23
190
1.27
0.39
4.7
3.0
1.0
0.8
ug/l
0.41
14
118
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
2.4
—
204.7
—
0
19
6
43
1.42
0.36
1.2
1.3
9.9
10.4
g/l
—
6
37
6
45
1.35
0.34
1.2
1.3
—
—
—
0
0
16
129
1.29
0.33
1.1
1.3
1.5
19.5
u/ml
—
7
54
41
369
1.19
0.31
2.4
2.0
98.5
92.7
pmol/l
0.22
21
181
22
187
1.23
0.30
2.4
1.7
1191.2
1143.1
nmol/l
0.08
13
135
13
103
1.30
0.30
1.6
1.8
—
—
—
0
0
58
540
1.17
0.29
2.8
3.2
51.4
52.7
u/l
0.04
51
499
13
104
1.29
0.28
1.8
3.0
11.1
9.3
umol/l
0.11
13
88
13
104
1.29
0.28
1.6
1.8
—
—
—
0
0
17
142
1.24
0.27
1.6
1.8
—
—
—
0
0
9
73
1.26
0.26
2.7
3.4
142.4
223.3
ng/l
—
9
63
16
134
1.23
0.24
4.0
3.0
1.1
2.4
e6/l
—
10
74
5
38
1.33
0.23
1.2
1.3
35.8
37.3
g/l
—
5
32
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
5
66
0.75
0.17
1.2
2.0
—
—
—
0
0
15
168
0.87
0.13
1.2
1.1
0.6
0.9
u/ml
—
5
56
26
241
1.11
0.12
1.6
1.6
1.2
1.4
mmol/l
0.44
17
208
5
43
1.17
0.10
1.2
1.3
3.6
3.0
g/l
—
5
35
5
47
1.07
0.09
2.0
2.4
0.9
1.2
%
—
5
47
6
53
1.14
0.09
1.5
1.4
—
—
—
0
0
36
353
1.03
0.01
2.5
2.2
88.3
77.5
nmol/l
1.17
28
303
15
147
1.02
0.00
3.9
2.7
0.5
1.1
e6/l
—
9
84
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
15.2
—
0
5
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
13.0
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
2.6
8.7
24.6
25.0
mmol/l
—
5
47
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
148.8
—
0
5
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
6.6
—
213.6
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
13.2
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
139.8
—
0
7
5
50
1.00
0.00
1.2
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
3.6
—
175.4
—
0
9
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_NOS – Melanoma in situ, other sites/unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).